share_log

B. Riley Securities Initiates Coverage On Tango Therapeutics With Buy Rating, Announces Price Target of $16

Benzinga ·  Dec 8, 2023 06:10

B. Riley Securities analyst Yuan Zhi initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment